A review on bio-availability enhancement techniques of poorly soluble drug

Khan, Anwar; Malviya, Rishabha; Sharma, Pramod K.
July 2014
International Journal of Pharmacy;Jul2014, Vol. 4 Issue 3, p260
Academic Journal
Solubility is the process of dissolution of solid in liquid phase to give a homogenous system and is one of the important parameter to achieve desired concentration of drug in systemic circulation for pharmacological response. Dissolution rate of poorly water-soluble drugs is rate limiting step for its bioavailability so increase in bioavailability is the major challenging task in drug development. Because only 8% of new drug candidates have both high solubility and permeability. For BCS class II drugs, enhancement of Solubility and hence bioavailability is important parameter before formulation of dosage form. Hydrophobic drugs often require high doses in order to reach therapeutic plasma concentrations after oral administration. Therapeutic effectiveness of a drug depends upon the bioavailability and ultimately upon the solubility of drug molecules. Various techniques are used for the improvement of the aqueous solubility, dissolution rate, and bioavailability of poorly water soluble drugs include size reduction, chemical modification, pH adjustment, solid dispersion, complexation, co-solvency, hydrotropy etc. the main emphasis of review article is to describe the techniques of solubilisation for the attainment of effective absorption with improved bioavailability.


Related Articles

  • Comparative evaluation of various solubility enhancement strategies for furosemide. Murtaza, Ghulam; Khan, Shujaat Ali; Najam-ul-Haq, Muhammad; Hussain, Izhar // Pakistan Journal of Pharmaceutical Sciences;Jul2014, Vol. 27 Issue 4, p963 

    Drugs with good solubility exhibit good oral absorption, and subsequently good bioavailability. Thus, most exigent phase of drug development practice particularly for oral dosage forms is the enhancement of drug solubility. This review describes various traditional and novel methodologies...

  • Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. Shweta Gupta; Rajesh Kesarla; Abdelwahab Omri // ISRN Pharmaceutics;2013, p1 

    Poorly water-soluble drug candidates are becoming more prevalent. It has been estimated that approximately 60-70% of the drug molecules are insufficiently soluble in aqueous media and/or have very low permeability to allow for their adequate and reproducible absorption from the gastrointestinal...

  • Recent Advances in Lipid-Based Formulation Technology. Porter, Christopher J. H.; Williams, Hywel D.; Trevaskis, Natalie L. // Pharmaceutical Research;Dec2013, Vol. 30 Issue 12, p2971 

    No abstract available.

  • SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUGS. Gohil, Tushar // Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia;2014, Vol. 25 Issue 1, p1 

    Aqueous solubility is a limiting factor in the oral bioavailability of a certain class of poorly water soluble drugs. A consequence of low aqueous solubility is a slow dissolution rate. For the drugs with low aqueous solubility and high permeability the dissolution rate will be the rate limiting...

  • Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug. Sharma1, Anshu; Jain, C.P. // International Journal of Drug Delivery;2011, Vol. 3 Issue 4, p149 

    Poorly water soluble compounds have solubility and dissolution related bioavailability problems. The present review deals in detail about solid dispersion technology and its manufacturing techniques at laboratory and industrial level. This highlight about various hydrophilic polymers used in...

  • Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors. Freiwald, Matthias; Schmid, Ulrike; Fleury, Angele; Wind, Sven; Stopfer, Peter; Staab, Alexander // Cancer Chemotherapy & Pharmacology;Apr2014, Vol. 73 Issue 4, p759 

    Purpose: This population pharmacokinetic model was developed to characterize the pharmacokinetics of the oral irreversible ErbB family blocker afatinib in patients with solid tumors and to investigate the impact of selected intrinsic and extrinsic factors. Methods: Data from 927 patients (4,460...

  • Recent Advances on Aqueous Solubility Prediction. Junmei Wang; Tingjun Hou // Combinatorial Chemistry & High Throughput Screening;Jun2011, Vol. 14 Issue 5, p328 

    No abstract available.

  • IMPROVEMENT OF DRUG SOLUBILITY USING SOLID DISPERSION. Kaur, Jatinder; Aggarwal, Geeta; Singh, Gurpreet; Rana, A.C. // International Journal of Pharmacy & Pharmaceutical Sciences;Mar2012, Vol. 4 Issue 2, p47 

    The solubility behaviour of drug is one of the most challenging aspects in formulation development. Thus a greater understanding of dissolution and absorption behaviour of drug with low aqueous solubility is required to successfully formulate them into more soluble and hence bioavailable drug...

  • Rate-Limiting Steps of Oral Absorption for Poorly Water-Soluble Drugs in Dogs; Prediction from a Miniscale Dissolution Test and a Physiologically-Based Computer Simulation. Ryusuke Takano; Kentaro Furumoto; Koji Shiraki; Noriyuki Takata; Yoshiki Hayashi; Yoshinori Aso; Shinji Yamashita // Pharmaceutical Research;Oct2008, Vol. 25 Issue 10, p2334 

    ABSTRACT Purpose  Nonlinear oral absorption due to poor solubility often impedes drug development. The purpose of this study was to elucidate the rate-limiting process in oral absorption of Biopharmaceutical Classification System (BCS) class II (low solubility–high permeability)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics